Details for New Drug Application (NDA): 016932
✉ Email this page to a colleague
NDA 016932 describes VALISONE, which is a drug marketed by Schering and is included in three NDAs. Additional details are available on the VALISONE profile page.
The generic ingredient in VALISONE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
The generic ingredient in VALISONE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 016932
| Tradename: | VALISONE |
| Applicant: | Schering |
| Ingredient: | betamethasone valerate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016932
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
